DE60017133D1 - Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose - Google Patents

Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose

Info

Publication number
DE60017133D1
DE60017133D1 DE60017133T DE60017133T DE60017133D1 DE 60017133 D1 DE60017133 D1 DE 60017133D1 DE 60017133 T DE60017133 T DE 60017133T DE 60017133 T DE60017133 T DE 60017133T DE 60017133 D1 DE60017133 D1 DE 60017133D1
Authority
DE
Germany
Prior art keywords
tuberculosis
treatment
control
naphthoquinone derivatives
naphthoquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60017133T
Other languages
English (en)
Other versions
DE60017133T2 (de
Inventor
Jacobus Johannes Marion Meyer
Namrita Lall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South African Medical Research Council
University of Pretoria
Medical Research Council of South Africa
Original Assignee
South African Medical Research Council
University of Pretoria
Medical Research Council of South Africa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South African Medical Research Council, University of Pretoria, Medical Research Council of South Africa filed Critical South African Medical Research Council
Application granted granted Critical
Publication of DE60017133D1 publication Critical patent/DE60017133D1/de
Publication of DE60017133T2 publication Critical patent/DE60017133T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
DE60017133T 1999-06-24 2000-06-22 Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose Expired - Fee Related DE60017133T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA9904176 1999-06-24
ZA994176 1999-06-24
PCT/IB2000/000837 WO2001000554A2 (en) 1999-06-24 2000-06-22 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis

Publications (2)

Publication Number Publication Date
DE60017133D1 true DE60017133D1 (de) 2005-02-03
DE60017133T2 DE60017133T2 (de) 2005-06-16

Family

ID=25587788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017133T Expired - Fee Related DE60017133T2 (de) 1999-06-24 2000-06-22 Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose

Country Status (9)

Country Link
US (1) US6835755B1 (de)
EP (1) EP1194137B1 (de)
JP (1) JP2003531813A (de)
CN (1) CN1192768C (de)
AP (1) AP1377A (de)
AU (1) AU5240700A (de)
DE (1) DE60017133T2 (de)
RU (1) RU2246299C2 (de)
WO (1) WO2001000554A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864955B1 (fr) * 2004-01-08 2006-03-10 Centre Nat Rech Scient Derives du gossypol, leur methode d'obtention et leurs utilisations
NZ566180A (en) * 2005-07-29 2011-04-29 Resverlogix Corp Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
CA2711103C (en) 2008-06-26 2016-08-09 Resverlogix Corp. Methods of preparing quinazolinone derivatives
WO2010079431A2 (en) 2009-01-08 2010-07-15 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
EP2408454A2 (de) 2009-03-18 2012-01-25 Resverlogix Corp. Neue entzündungshemmende mittel
KR101892987B1 (ko) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 신규한 소염제
CN101669927B (zh) * 2009-09-22 2012-02-29 中山大学 蒽醌zsu-h85在制备抗耻垢分枝杆菌药物中的应用
JP5992049B2 (ja) 2011-11-01 2016-09-14 レスバーロジックス コーポレイション 置換されたキナゾリノンのための経口速放性製剤
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． ブロモドメイン阻害剤としての新規複素環式化合物
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
CN106176709B (zh) * 2015-05-26 2020-02-07 顺天乡大学校产学协力团 治疗结核病用药物组合物及其制备方法
KR101851377B1 (ko) * 2015-05-26 2018-06-05 순천향대학교 산학협력단 결핵 치료용 약학 조성물 및 이의 제조방법
CN109730984A (zh) * 2019-01-18 2019-05-10 天津国际生物医药联合研究院 1,4-萘醌在抗结核分枝杆菌感染中的应用
CN110075095A (zh) * 2019-04-15 2019-08-02 天津国际生物医药联合研究院 1,4-萘醌在抗结核分枝杆菌感染中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837399A (en) * 1988-05-10 1989-06-06 The United States Of America As Represented By The Secretary Of Agriculture Napthoquinone antibiotics from fuserium solani

Also Published As

Publication number Publication date
AU5240700A (en) 2001-01-31
DE60017133T2 (de) 2005-06-16
CN1372464A (zh) 2002-10-02
EP1194137B1 (de) 2004-12-29
CN1192768C (zh) 2005-03-16
AP2002002393A0 (en) 2002-03-31
US6835755B1 (en) 2004-12-28
WO2001000554A2 (en) 2001-01-04
WO2001000554A3 (en) 2001-07-05
RU2246299C2 (ru) 2005-02-20
EP1194137A2 (de) 2002-04-10
AP1377A (en) 2005-03-18
JP2003531813A (ja) 2003-10-28

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE69830660D1 (de) Behandlung von atemstillstand im schlaf
DE69927971D1 (de) Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
DE60017133D1 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60233265D1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
ATE415392T1 (de) Pyrimidinonderivate und deren verwendung bei der behandlung von atherosklerose
DE60017894D1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
DE60140377D1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
ATE229502T1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60001725D1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee